25.07 10:02 | MÄRKTE EUROPA/Schwächer - Bilanzsaison mit mehr Schatten als Licht |
25.07 09:28 | dpa-AFX: *LONZA +7,9% - STARKE HALBJAHRESZAHLEN STÜTZEN |
25.07 07:55 | dpa-AFX: Lonza Group H1 Profit, Sales Drop |
25.07 07:08 | dpa-AFX: *LONZA GROUP H1 CORE EBITDA CHF 893 MLN VS. CHF 922 MLN LAST YEAR |
25.07 07:07 | dpa-AFX: *LONZA GROUP H1 CORE EPS CHF 7.02 VS. CHF 6.89 LAST YEAR |
25.07 07:07 | dpa-AFX: *LONZA GROUP H1 IFRS EPS CHF 4.61 VS CHF 5.54 LAST YEAR |
25.07 07:07 | dpa-AFX: *LONZA GROUP H1 IFRS NET INCOME CHF 330 MLN VS. CHF 411 MLN LAST YEAR |
25.07 07:07 | dpa-AFX: *LONZA GROUP H1 EBITDA CHF 862 MLN VS. CHF 899 MLN LAST YEAR |
25.07 07:07 | dpa-AFX: *LONZA GROUP H1 EBIT CHF 534 MLN VS. CHF 540 MLN LAST YEAR |
25.07 07:04 | dpa-AFX: *LONZA GROUP H1 SALES CHF 3.057 BLN VS. CHF 3.078 BLN LAST YEAR |
25.07 07:01 | Lonza Nominates Juan Andres and Eric Drapé as Independent Board Members |
25.07 07:00 | dpa-AFX: EQS-News: Lonza Nominates Juan Andres and Eric Drapé as Independent Board Members (english) |
25.07 07:00 | dpa-AFX: EQS-News: Lonza Nominates Juan Andres and Eric Drapé as Independent Board Members (english) |
25.07 07:00 | Lonza Nominates Juan Andres and Eric Drapé as Independent Board Members |
25.07 06:57 | 2024 Halbjahresperformance der Lonza Gruppe in Übereinstimmung mit Gesamt-jahresprognose: Umsatzwachstum von 1.8% kWk und 29.2% Kern-EBITDA-Marge |
25.07 06:57 | Lonza Group H1 2024 Performance Well On Track to Deliver Full-Year Outlook: Sales Up 1.8% CER and 29.2% CORE EBITDA Margin |
25.07 06:56 | Lonza Group H1 2024 Performance Well On Track to Deliver Full-Year Outlook: Sales Up 1.8% CER and 29.2% CORE EBITDA Margin |
25.07 06:56 | 2024 Halbjahresperformance der Lonza Gruppe in Übereinstimmung mit Gesamt-jahresprognose: Umsatzwachstum von 1.8% kWk und 29.2% Kern-EBITDA-Marge |
25.07 06:56 | dpa-AFX: EQS-Adhoc: Lonza Group H1 2024 Performance Well On Track to Deliver Full-Year Outlook: Sales Up 1.8% CER and 29.2% CORE EBITDA Margin (english) |
25.07 06:56 | dpa-AFX: EQS-Adhoc: Lonza Group H1 2024 Performance Well On Track to Deliver Full-Year Outlook: Sales Up 1.8% CER and 29.2% CORE EBITDA Margin (english) |
|